JP Morgan Chase’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

JP Morgan Chase’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,816	Closed	-$93K	–	7379
2022 Q3	$93K	Sell	8,816 -817,156	-99%	-$8.56M	﹤0.01%	5317
2022 Q2	$8.59M	Buy	825,972 +819,345	+12,364%	+$5.08M	﹤0.01%	2296
2022 Q1	$43K	Sell	6,627 -8,322	-56%	-$54.9K	﹤0.01%	5854
2021 Q4	$125K	Sell	14,949 -21,982	-60%	-$161K	﹤0.01%	5581
2021 Q3	$310K	Sell	36,931 -443,598	-92%	-$3.95M	﹤0.01%	5004
2021 Q2	$5.47M	Buy	+480,529	New	+$5.56M	﹤0.01%	2973

JP Morgan Chase's CNVY Position: Q4 2022 in Review

JP Morgan Chase sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q4 2022, closing a stake of 8,816 shares — an estimated $93K sold.

JP Morgan Chase first reported a position in CNVY in Q2 2021 and held it in 6 quarters. The position peaked at $8.59M in Q2 2022. 0 funds tracked by Wall St. Rank hold CNVY as of Q4 2022.

JP Morgan Chase reported no remaining Convey Health Solutions Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
JP Morgan Chase sold 8,816 Convey Health Solutions Holdings, Inc. shares in Q4 2022, an estimated $93K.
JP Morgan Chase first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 6 quarters.
JP Morgan Chase's Convey Health Solutions Holdings, Inc. position peaked at $8.59M in Q2 2022.
0 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.